Knight Therapeutics (KHTRF) News Today $3.78 +0.09 (+2.44%) (As of 11/18/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Knight Therapeutics price target lowered to C$7.50 from C$8 at Raymond JamesNovember 15 at 3:05 AM | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Knight Therapeutics (KHTRF)November 9, 2024 | markets.businessinsider.comKnight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comKnight Therapeutics Inc (KHTRF) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Margin ...November 8, 2024 | finance.yahoo.comKnight Therapeutics Reports Third Quarter 2024November 7, 2024 | globenewswire.comNotice of Knight Therapeutics' Third Quarter 2024 Results Conference CallOctober 31, 2024 | globenewswire.comKnight Therapeutics Inc (KHTRF) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic ...October 10, 2024 | finance.yahoo.comKnight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing CompaniesSeptember 27, 2024 | globenewswire.comKnight Therapeutics Reports Second Quarter 2024August 8, 2024 | globenewswire.comNotice of Knight Therapeutics' Second Quarter 2024 Results Conference CallAugust 1, 2024 | globenewswire.comKnight Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 12, 2024 | finance.yahoo.comKnight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1May 9, 2024 | finance.yahoo.comKnight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin AmericaMay 9, 2024 | globenewswire.comKnight Therapeutics Reports First Quarter 2024 ResultsMay 9, 2024 | globenewswire.comKnight Therapeutics Inc. announces voting results from the Annual General MeetingMay 8, 2024 | globenewswire.comKnight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York CityMay 7, 2024 | finance.yahoo.comNotice of Knight Therapeutics' First Quarter 2024 Results Conference CallMay 2, 2024 | globenewswire.comKnight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversityMarch 28, 2024 | finance.yahoo.comKnight Therapeutics Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest ForecastsMarch 24, 2024 | finance.yahoo.comKnight Therapeutics Reports Fourth Quarter and Year-End 2023 ResultsMarch 21, 2024 | globenewswire.comKnight Therapeutics Inc.March 14, 2024 | baystreet.caNotice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference CallMarch 14, 2024 | globenewswire.comKnight Therapeutics price target raised by C$0.50 at Raymond JamesMarch 6, 2024 | realmoney.thestreet.comKnight Therapeutics Inc. Celebrates its First Decade of SuccessFebruary 28, 2024 | globenewswire.comKnight Therapeutics Announces Regulatory Submission of Fostamatinib in BrazilFebruary 21, 2024 | globenewswire.comKnight Therapeutics Inc.'s (TSE:GUD) top owners are retail investors with 43% stake, while 23% is held by private companiesFebruary 4, 2024 | finance.yahoo.comG2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN KNIGHT THERAPEUTICS INC.January 31, 2024 | finance.yahoo.comRBC Capital Keeps Their Buy Rating on Knight Therapeutics (KHTRF)November 12, 2023 | markets.businessinsider.comKnight Therapeutics: Strong Q3 Results and Positive Outlook Drive Buy RatingNovember 11, 2023 | markets.businessinsider.comKnight Therapeutics reports Q3 resultsNovember 9, 2023 | msn.comNotice of Knight Therapeutics' Third Quarter 2023 Results Conference CallNovember 2, 2023 | finance.yahoo.comKnight Therapeutics (TSE:GUD) investors are sitting on a loss of 44% if they invested five years agoOctober 30, 2023 | finance.yahoo.comKnight Therapeutics Inc. ocupa el puesto 90 en la quinta clasificación anual de The Globe and Mail de Canada's Top Growing Companies.October 3, 2023 | prnewswire.comKnight Therapeutics Inc. ocupa a 90ª posição no quinto ranking anual das Empresas de Maior Crescimento do Canadá (Canada's Top Growing Companies) segundo a The Globe and Mail.October 3, 2023 | prnewswire.comExecutive Chairman of Knight Therapeutics Jonathan Goodman Buys More StockSeptember 29, 2023 | finance.yahoo.comKnight Therapeutics (KHTRF) Receives a Hold from Stifel NicolausAugust 10, 2023 | markets.businessinsider.comNotice of Knight Therapeutics’ Second Quarter 2023 Results Conference CallAugust 3, 2023 | financialpost.comAnalysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Knight Therapeutics (OtherKHTRF)July 12, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Knight Therapeutics (KHTRF)May 15, 2023 | markets.businessinsider.comKnight Therapeutics Reports First Quarter 2023 ResultsMay 11, 2023 | finance.yahoo.comKnight Therapeutics Inc. announces voting results from the Annual General MeetingMay 10, 2023 | finance.yahoo.comClosing Bell: Knight Therapeutics Inc flat on Tuesday (GUD)May 2, 2023 | theglobeandmail.comClosing Bell: Knight Therapeutics Inc down on Tuesday (GUD)April 25, 2023 | theglobeandmail.comA number of insiders bought Knight Therapeutics Inc. (TSE:GUD) stock last year, which is great news for shareholdersApril 17, 2023 | finance.yahoo.comClosing Bell: Knight Therapeutics Inc up on Thursday (GUD)April 7, 2023 | theglobeandmail.comBloom Burton Keeps Their Buy Rating on Knight Therapeutics (KHTRF)March 26, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Knight Therapeutics (KHTRF)March 24, 2023 | markets.businessinsider.comG2S2 CAPITAL INC. ANNOUNCES INVESTMENT IN KNIGHT THERAPEUTICS INC.March 24, 2023 | finance.yahoo.comStifel Nicolaus Remains a Hold on Knight Therapeutics (KHTRF)March 23, 2023 | markets.businessinsider.comBerkadia Forges Alliance With Knight FrankJanuary 26, 2023 | finance.yahoo.com Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address The pin that pops the AI bubble (Ad)My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. KHTRF Media Mentions By Week KHTRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KHTRF News Sentiment▼-0.630.57▲Average Medical News Sentiment KHTRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KHTRF Articles This Week▼20▲KHTRF Articles Average Week Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News ACRHF News ACRDF News LBTSF News AZFL News ERBB News AWWH News AVTBF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KHTRF) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
